[1] 卢锡林, 吴婉玲, 黄永青, 等. 缺血性脑卒中患者纤维蛋白原水平与颈动脉粥样硬化关系的研究[J]. 国际内科学杂志, 2007, 34(5):251-252, 292. [2] 何蕴, 马丽丽, 邢秀萍. 进展性脑梗死纤维蛋白原和纤溶指标的动态变化及其意义[C]//中华医学会第七次全国神经病学学术会议论文汇编. 南京, 2004:422. [3] SUMI H, HAMADA H, TSUSHIMA H, et al. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto;a typical and popular soybean food in the Japanese diet[J]. Experientia, 1987, 43(10):1110-1111. [4] 张艳, 吴文惠, 周培根, 等. 海洋微生物来源纤溶活性化合物的筛选及其分离[J]. 中国海洋药物, 2008, 27(6):39-43. [5] GUO R H, ZHANG Y T, DUAN D, et al. Fibrinolytic evaluation of compounds isolated from a marine fungus Stachybotrys longispora FG216[J]. Chin J Chem, 2016, 34(11):1194-1198. [6] GAO C L, SHEN Q, TANG P J, et al. In vitro study of the fibrinolytic activity via single chain urokinase-type plasminogen activator and molecular docking of FGFC1[J]. Molecules, 2021, 26(7):1816. [7] 田逸君, 郑怡文, 朱玉平, 等. 雷公藤内酯醇的遗传毒性评价[J]. 药学实践杂志, 2016, 34(3):215-218. [8] 中华人民共和国卫生部. 新药(西药)临床前研究指导原则汇编(药学, 药理, 毒理学)[G]. 北京:中华人民共和国卫生部药政局, 1993. [9] ICH指导委员会. 药品注册的国际技术要求-安全性部分[M]. 北京:人民卫生出版社, 2001:37-61. [10] OECD.Test Guidance 471, Bacterial Reverse Mutation Test. In:OECD Guidance For Testing of Chemicals[S]. Paris:Organization for Economic Cooperation & Development, 1997. [11] OECD.Test Guidance 474. Mammalian Erythrocyte Micronucleus Test. In:OECD Guidance for Testing of Chemicals[S]. Paris:Organization for Economic Cooperation & Development. 1997. [12] OECD. Test Guidance 473. In vitro Mammalian Chromosome Aberration Test In:OECD Guidance for Testing of Chemicals[S]. Paris:Organization for Economic Cooperation & Development, 1997. [13] 侍雯婧, 田逸君, 黄才国, 等. Wentilactone A的遗传毒性评价[J]. 药学实践杂志, 2020, 38(6):533-538. [14] Guo R H, Duan D, Hong S T, et al. A marine fibrinolytic compound FGFC1 stimulating enzymatic kinetic parameters of a reciprocal activation system based on a single chain urokinase-type plasminogen activator and plasminogen[J].Process Biochem, 2018, 68(10):190-196. [15] YAN T, WU W H, SU T W, et al. Effects of a novel marine natural product:pyrano indolone alkaloid fibrinolytic compound on thrombolysis and hemorrhagic activities in vitro and in vivo[J]. Arch Pharm Res, 2015, 38(8):1530-1540. [16] SU T W, WU W H, YAN T, et al. Pharmacokinetics and tissue distribution of a novel marine fibrinolytic compound in Wistar rat following intravenous administrations[J]. J Chromatogr B, 2013, 942/943:77-82. |